Clinical Trial Update: Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cinacalcet for end stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Sensipar (cinacalcet) (cinacalcet)

Snippet

Sponsor: Amgen | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED